Pharmaceutical Business review

Akorn’s CEO to leave

The committee consists of John Kapoor, chairman of the board of directors and directors Randall Wall and Jerry Ellis.

Dr Kapoor said: “Our current management team will execute the strategy for the company to achieve continued growth and success. We will endeavor to identify a replacement as soon as practicable.”